Sylvamo Corporation: Near-Cycle-Low FCF Creates An Attractive Recovery Opportunity
Sylvamo is facing temporary headwinds from European weakness, lost capacity, operational issues, and elevated capex, pushing earnings and FCF near cyclical lows. North American supply cuts and tariffs could strengthen pricing, while Eastover's upgrade and operational improvements should support higher margins and EBITDA. A cyclical recovery in Europe and Latin America, combined with normalized capex, could eventually restore SLVM to more than $300 million of annual FCF.